UPDATE: Aegerion Pharma Commences Phase 3 Clinical Trial in Japan, Will Evaluate Lomitapipde for Treatment of HoFH
April 09, 2014 at 08:07 AM EDT
Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR), a biopharmaceutical company dedicated to the development and commercialization of novel ...